Innovation Pharmaceuticals - Clinical Trial Testing of Brilacidin Against SARS-CoV-2 (COVID-19) Targeted to Commence Q4 2020

Stock Information for Innovation Pharmaceuticals Inc

Loading

Please wait while we load your information from QuoteMedia.